Public health grant NIDA grant support and ongoing NSIHT research indicate a strong relationship with federal funding bodies and a focus on toxicology and drug trend analysis, presenting an opportunity to offer expanded research services, data analytics, and grant-ready project partnerships.

Toxicology leadership Established toxicology expertise and a long history of solving complex drug and consumer product safety challenges position the firm to diversify offerings in hazard assessment, safety testing, and regulatory compliance services for pharma and CPG clients.

Public health focus Core mission spanning research, education, prevention, and treatment aligns with opportunities in government contracting, hospital systems, and public health programs seeking integrated safety and compliance solutions.

Moderate revenue scale With estimated annual revenue in the mid seven figures, there is room to upsell expanded analytics, technology-enabled surveillance, and specialized consulting to existing clients while pursuing larger contract opportunities.

Tech stack leverage Current digital tools and platforms indicate readiness for data-driven services; emphasize offerings in data integration, secure reporting dashboards, and web-based education or prevention programs tailored to healthcare and regulatory clients.